Tag: stroke recovery
Kandu announces positive functional outcomes and low readmission rates in novel...
Kandu Health has announced preliminary outcomes from the first 40 stroke survivors served by its novel stroke recovery programme, which intends to support stroke...
Early administration of antiplatelets may improve post-thrombectomy outcomes in stroke patients
Administering antiplatelet medication within 24 hours of a mechanical thrombectomy procedure may help stroke patients recover more successfully and prevent high-risk individuals from experiencing...
Kandu Health appoints new CEO and enrols first 50 patients in...
Imperative Care recently announced the appointment of Kirsten Carroll as the new CEO of Kandu Health—a digital health startup with the aim of improving quality...
Reach Neuro receives Breakthrough Device designation for restorative stimulation device in...
Reach Neuro has been granted a Breakthrough Device designation by the US Food and Drug Administration (FDA) for its Avantis platform, which uses small...
Imperative Care announces formation of digital stroke recovery company Kandu Health
Imperative Care has announced the formation of digital health startup Kandu Health as an independent company, with the aim of “changing the course of stroke...
Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control
Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses...
MindMaze and University of Auckland partner on trial evaluating immersive intervention...
MindMaze—in partnership with the University of Auckland (Auckland, New Zealand)—has announced a new study that will aim to show the merits of early, immersive...
Neuromodulation for post-stroke recovery advancing on several fronts
As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...
Treating chronic-stage stroke with hyperbaric oxygen therapy
Mohammed Elamir (The Villages, USA) and Amir Hadanny (Be'er Ya'akov, Israel) mark this year’s Stroke Awareness Month by discussing hyperbaric oxygen therapy (HBOT)—an emerging...
ESOC 2022: New study links gut microbiota strains with more severe...
A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut...
ESOC 2022: ‘Brain-age’ biomarkers predict stroke recovery more accurately than chronological...
Stroke experts have identified how radiomics—an emerging, image-quantifying technology—can be used to extract biomarkers from clinical brain magnetic resonance imaging (MRI) scans in stroke...
First patient enrolled in pivotal EMAGINE trial of electromagnetic field therapy...
BrainQ has announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital (Washington, USA) in the pivotal, randomised, double-blind, multicentre EMAGINE...
Return to work and depressive symptoms in young stroke survivors
Matthias Volz (University of Kassel, Kassel, Germany), Simon Ladwig and Katja Werheid (both Humboldt-Universität zu Berlin, Berlin, Germany) discuss the burden of post-stroke depression...
Stroke study reveals optimal timing and intensity for arm and hand...
A phase II, randomised clinical trial has found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should...
ESOC 2021: AI can calculate personalised risk of having another stroke
Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate assessment of their risk of suffering a recurrence, according...
MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...
MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...
IpsiHand System: New device for facilitating stroke rehabilitation gains FDA approval
The US Food and Drug Administration (FDA) has authorised marketing of a new device indicated for use in patients aged 18 and older undergoing...
UK charity funds “world-first” study into long-term COVID-19 impact on stroke
Leading UK charity the Stroke Association is funding what it claims will be the world’s first study to determine the long-term impact of COVID-19...
BrainQ trial results show a potential reduction in disability after stroke
BrainQ, an Israeli start-up with an artificial intelligence- (AI) powered therapeutic platform, has announced the results from a randomised controlled trial (RCT), showing 77%...
The post-stroke brain’s ability to recover and rewire itself peaks at...
A study published in Neurorehabilitation and Neural Repair finds that the capacity of the human brain to recover and rewire itself peaks around two...
